Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 331401 - 331420 out of 566181 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Italy | (L04AC05) ustekinumab (adm: P) | PYZCHIVA*1 siringa SC 45 mg 0,5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | SAMSUNGBIOEPISNLB.V. |
| Italy | (L04AC05) ustekinumab (adm: P) | STELARA*1 flaconcino SC 45 mg 0,5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSENCILAGINTERNAT.N.V. |
| Italy | (L04AC05) ustekinumab (adm: P) | STELARA*1 siringa SC 45 mg 0,5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSENCILAGINTERNAT.N.V. |
| Italy | (L04AC05) ustekinumab (adm: P) | UZPRUVO*1 siringa SC 45 mg 0,5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | STADAARZNEIMITTELAG |
| Italy | (L04AC05) ustekinumab (adm: P) | WEZENLA*1 siringa SC 45 mg 0,5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | AMGENTECHNOLOGY(IRELAND)UC |
| Italy | (L04AC05) ustekinumab (adm: P) | IMULDOSA*1 siringa preriempita SC 1 ml 90 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Psoriasis;Arthritis, Psoriatic | ACCORDHEALTHCARESLU |
| Italy | (L04AC05) ustekinumab (adm: P) | OTULFI*1 siringa SC 90 mg 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative | FRESENIUSKABIDEUTSCH.GMBH |
| Italy | (L04AC05) ustekinumab (adm: P) | PYZCHIVA*1 siringa SC 90 mg 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | SAMSUNGBIOEPISNLB.V. |
| Italy | (L04AC05) ustekinumab (adm: P) | STELARA*1 siringa SC 90 mg 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSENCILAGINTERNAT.N.V. |
| Italy | (L04AC05) ustekinumab (adm: P) | UZPRUVO*1 siringa SC 90 mg 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | STADAARZNEIMITTELAG |
| Italy | (L04AC05) ustekinumab (adm: P) | WEZENLA*1 siringa SC 90 mg 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | AMGENTECHNOLOGY(IRELAND)UC |
| Italy | (L04AC07) tocilizumab (adm: P) | ROACTEMRA*1 flaconcino EV 10 ml 20 mg/ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | ROACTEMRA*1 flaconcino EV 20 ml 20 mg/ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | ROACTEMRA*1 flaconcino EV 4 ml 20 mg/ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | TYENNE*1 flaconcino EV 20 mg/ml 10 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIDEUTSCH.GMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | TYENNE*1 flaconcino EV 20 mg/ml 20 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIDEUTSCH.GMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | TYENNE*1 flaconcino EV 20 mg/ml 4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIDEUTSCH.GMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | ROACTEMRA*4 siringhe SC 162 mg 0,9 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | TYENNE*4 penne SC 162 mg 0,9 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIDEUTSCH.GMBH |
| Italy | (L04AC07) tocilizumab (adm: P) | TYENNE*4 siringhe SC 162 mg 0,9 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIDEUTSCH.GMBH |
Pages
